U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07130565) titled 'Pan-Amyloid PET/CT in Various Amyloid-Related Disease' on Aug. 12.
Brief Summary: To evaluate the potential usefulness of 18F-92/AV45/TPZA/FT8, 11C-PIB positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Pan-Amyloid-related disease patients.
Study Start Date: Nov. 01, 2023
Study Type: OBSERVATIONAL
Condition:
Amyloid
Cardiac Amyloidosis
Amyloidosis
Intervention:
DIAGNOSTIC_TEST: 18F-92/AV45/TPZA/FT8, 11CPIB
Each subject receive a single intravenous injection of 18F-92/AV45/TPZA/FT8, 11C-PIB and undergo PET/CT or MRI imaging within the specificed time.
Recru...